Verschraegen, C. F., Jerusalem, G., McClay, E. F., Iannotti, N., Redfern, C. H., Bennouna, J., Chen, F. L., Kelly, K., Mehnert, J., Morris, J. C., Taylor, M., Spigel, D., Wang, D., Grote, H. J., Zhou, D., Munshi, N., Bajars, M., & Gulley, J. L. (2020). efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127563943.0x000031